ÇѸ²´ëÇб³¼º½Éº´¿ø

¹Ú°æÇÏ ±³¼ö

  • Àü¹®¼¾ÅÍ ½ÉÀåÇ÷°ü¼¾ÅÍ
  • Áø·á°ú ¼øȯ±â³»°ú

Àü¹®Áø·áºÐ¾ß

ÇãÇ÷¼º½ÉÁúȯ (Çù½ÉÁõ, ½É±Ù°æ»ö), µ¿¸Æ°æÈ­, °íÇ÷¾Ð, °íÁöÇ÷Áõ, °æÇÇÀû ´ëµ¿¸ÆÆǸ· ÁßÀç¼ú

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2025-01-13 ~ 2025-01-18)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¼¾ÅÍÁø·á¼¾ÅÍÁø·á
¿ÀÈÄ ¼¾ÅÍÁø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

2007.03 ~ 2010.12¿ï»ê´ëÇб³ ´ëÇпø ¹Ú»ç

1996.03 ~ 2006.02¿ï»ê´ëÇб³ ´ëÇпø ¼®»ç

1989.03 ~ 1996.02ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ Çлç

°æ·Â

°æ·Â

2012.03 ~ ÇѸ²´ëÇб³ ¼º½Éº´¿ø ¼øȯ±â³»°ú ±³¼ö

2016.03 ~ 2018.03ÇѸ²´ëÇб³ ¼º½Éº´¿ø ½ÉÇ÷°ü ¼¾ÅÍÀå

2008.03 ~ 2012.02ÇѸ²´ëÇб³ ÇÑ°­¼º½Éº´¿ø ¼øȯ±â³»°ú ±³¼ö

2004.05 ~ 2006.02¼­¿ï¾Æ»êº´¿ø ½ÉÀå³»°ú ÀÓ»ó°­»ç

1997.03 ~ 2001.02¼­¿ï¾Æ»êº´¿ø ³»°ú Àü°øÀÇ

1996.03 ~ 1997.02¼­¿ï¾Æ»êº´¿ø ÀÎÅÏ

ÇÐȸȰµ¿

ÇÐȸȰµ¿

2010-present Reviewer, Journal of Cardiovascular Ultrasound

2011-present Reviewer, American Journal of Hypertension

2011-present Reviewer, Journal of Interventional Cardiology

2020-present Reviewer, International Journal of Molecular Science

´ëÇÑ ÁßȯÀÚÀÇÇÐȸ Á¤È¸¿ø

´ëÇÑ ½ÉÃÊÀ½ÆÄÇÐȸ Á¤È¸¿ø

´ëÇÑ ½ÉÀåÇÐȸ Á¤È¸¿ø

½ÉÇ÷°ü¿¬±¸Àç´Ü ÀÌ»ç

2010-present Reviewer, Hypertension Research

´ëÇÑ ÁßÀç½Ã¼úÇÐȸ Á¤È¸¿ø

³í¹®

Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease (NEW ENGLAND JOURNAL OF MEDICINE)

Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery (Journal of the American College of Cardiology)

Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI rationale and design of the TAILORED-CHIP trial (EUROINTERVENTION)

The Risk of Venous Thromboembolism in Korean Patients with Breast Cancer: A Single-Center Experience (CANCERS)

Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial (American Heart Journal)

The Effects of Atorvastatin on Global Cerebral Ischemia-Induced Neuronal Death (INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES)

Association between 10-Year Atherosclerotic Cardiovascular Disease Risk and Vascular Endothelial Function in Patients with Vasospastic Angina (Cardiology (Switzerland))

The Effects of Atorvastatin on Global Cerebral Ischemia-Induced Neuronal Death (International Journal of Molecular Sciences)

Association between 10-Year Atherosclerotic Cardiovascular Disease Risk and Vascular Endothelial Function in Patients with Vasospastic Angina (Cardiology)

Transient Receptor Potential Melastatin 2 (TRPM2) Inhibition by Antioxidant,N-Acetyl-l-Cysteine, Reduces Global Cerebral Ischemia-Induced Neuronal Death (INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES)

°Ç°­¸Å°ÅÁø